amsacrine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ruggeri, L | 1 |
| Fumagalli, F | 1 |
| Bernasconi, F | 1 |
| Semeraro, F | 1 |
| Meessen, JMTA | 1 |
| Blanda, A | 1 |
| Migliari, M | 1 |
| Magliocca, A | 1 |
| Gordini, G | 1 |
| Fumagalli, R | 1 |
| Sechi, G | 1 |
| Pesenti, A | 1 |
| Skrifvars, MB | 1 |
| Li, Y | 1 |
| Latini, R | 1 |
| Wik, L | 1 |
| Ristagno, G | 1 |
1 other study available for amsacrine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Amplitude Spectrum Area of ventricular fibrillation to guide defibrillation: a small open-label, pseudo-randomized controlled multicenter trial.
Topics: Adult; Amsacrine; Cardiopulmonary Resuscitation; COVID-19; Electric Countershock; Humans; Ventricula | 2023 |